{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T07:15:26Z","timestamp":1768720526227,"version":"3.49.0"},"reference-count":14,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,9,1]]},"DOI":"10.1373\/clinchem.2006.073460","type":"journal-article","created":{"date-parts":[[2006,8,29]],"date-time":"2006-08-29T16:01:16Z","timestamp":1156867276000},"page":"1640-1642","source":"Crossref","is-referenced-by-count":31,"title":["Aldosterone Assays: An Urgent Need for Improvement"],"prefix":"10.1093","volume":"52","author":[{"given":"Michael","family":"Stowasser","sequence":"first","affiliation":[{"name":"Endocrine Hypertension, Research Centre, Greenslopes and, Princess Alexandra Hospitals, University of Queensland, Brisbane, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard D","family":"Gordon","sequence":"first","affiliation":[{"name":"Endocrine Hypertension, Research Centre, Greenslopes and, Princess Alexandra Hospitals, University of Queensland, Brisbane, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2006,9,1]]},"reference":[{"key":"2020022801235579000_R1","doi-asserted-by":"crossref","unstructured":"Schirpenbach C, Seiler L, Maser-Gluth C, Beuschlein F, Reincke M, Bidlingmaier M. Automated chemiluminescence-immunoassay for aldosterone during dynamic testing: comparison to radioimmunoassays with and without extraction steps. Clin Chem2006;52:1749-1755.","DOI":"10.1373\/clinchem.2006.068502"},{"key":"2020022801235579000_R2","doi-asserted-by":"crossref","unstructured":"Gordon RD, Klemm SA, Tunny TJ, Stowasser M. Primary aldosteronism: hypertension with a genetic basis. Lancet1992;340:159-161.","DOI":"10.1016\/0140-6736(92)93225-C"},{"key":"2020022801235579000_R3","doi-asserted-by":"crossref","unstructured":"Young WF, Jr. Primary aldosteronism: a common and curable form of hypertension. Cardiol Rev1999;7:207-214.","DOI":"10.1097\/00045415-199907000-00012"},{"key":"2020022801235579000_R4","doi-asserted-by":"crossref","unstructured":"Lim PO, Rodgers P, Cardale K, Watson AD, MacDonald TM. Potentially high prevalence of primary aldosteronism in a primary-care population. Lancet1999;353:40.","DOI":"10.1016\/S0140-6736(05)74868-6"},{"key":"2020022801235579000_R5","doi-asserted-by":"crossref","unstructured":"Loh KC, Koay ES, Khaw MC, Emmanuel SC, Young WF, Jr. Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore. J Clin Endocrinol Metab2000;85:2854-2859.","DOI":"10.1210\/jc.85.8.2854"},{"key":"2020022801235579000_R6","doi-asserted-by":"crossref","unstructured":"Gordon RD, Stowasser M, Tunny TJ, Klemm SA, Rutherford JC. High incidence of primary aldosteronism in 199 patients referred with hypertension. Clin Exp Pharmacol Physiol1994;21:315-318.","DOI":"10.1111\/j.1440-1681.1994.tb02519.x"},{"key":"2020022801235579000_R7","doi-asserted-by":"crossref","unstructured":"Mulatero P, Rabbia F, Milan A, Paglieri C, Morello F, Chiandussi L, et al. Drug effects on aldosterone\/plasma renin activity ratio in primary aldosteronism. Hypertension2002;40:897-902.","DOI":"10.1161\/01.HYP.0000038478.59760.41"},{"key":"2020022801235579000_R8","doi-asserted-by":"crossref","unstructured":"Calhoun DA, Nishizaka MK, Zaman MA, Thakkar RB, Weissmann P. Hyperaldosteronism among black and white subjects with resistant hypertension. Hypertension2002;40:892-896.","DOI":"10.1161\/01.HYP.0000040261.30455.B6"},{"key":"2020022801235579000_R9","doi-asserted-by":"crossref","unstructured":"Montori VM, Schwartz GL, Chapman AB, Boerwinkle E, Turner ST. Validity of the aldosterone-renin ratio used to screen for primary aldosteronism. Mayo Clin Proc2001;76:877-882.","DOI":"10.4065\/76.9.877"},{"key":"2020022801235579000_R10","doi-asserted-by":"crossref","unstructured":"Stowasser M, Gordon RD, Rutherford JC, Nikwan NZ, Daunt N, Slater GJ. Diagnosis and management of primary aldosteronism. J Renin Angiotensin Aldosterone Syst2001;2:156-169.","DOI":"10.3317\/jraas.2001.022"},{"key":"2020022801235579000_R11","doi-asserted-by":"crossref","unstructured":"Gordon RD. The challenge of more robust and reproducible methodology in screening for primary aldosteronism. J Hypertens2004;22:251-255.","DOI":"10.1097\/00004872-200402000-00006"},{"key":"2020022801235579000_R12","doi-asserted-by":"crossref","unstructured":"Ferrari P, Shaw SG, Nicod J, Saner E, Nussberger J. Active renin versus plasma renin activity to define aldosterone-to-renin ratio for primary aldosteronism. J Hypertens2004;22:377-381.","DOI":"10.1097\/00004872-200402000-00023"},{"key":"2020022801235579000_R13","doi-asserted-by":"crossref","unstructured":"Perschel FH, Schemer R, Seiler L, Reincke M, Deinum J, Maser-Gluth C, et al. Rapid screening test for primary hyperaldosteronism: ratio of plasma aldosterone to renin concentration determined by fully automated chemiluminescence immunoassays. Clin Chem2004;50:1650-1655.","DOI":"10.1373\/clinchem.2004.033159"},{"key":"2020022801235579000_R14","doi-asserted-by":"crossref","unstructured":"Giacchetti G, Ronconi V, Lucarelli G, Boscaro M, Mantero F. Analysis of screening and confirmatory tests in the diagnosis of primary aldosteronism: need for a standardized protocol. J Hypertens2006;24:737-745.","DOI":"10.1097\/01.hjh.0000217857.20241.0f"}],"container-title":["Clinical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/clinchem\/article-pdf\/52\/9\/1640\/32685563\/clinchem1640.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/clinchem\/article-pdf\/52\/9\/1640\/32685563\/clinchem1640.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,28]],"date-time":"2020-02-28T01:24:42Z","timestamp":1582853082000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/clinchem\/article\/52\/9\/1640\/5626959"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9,1]]},"references-count":14,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2006,9,1]]},"published-print":{"date-parts":[[2006,9,1]]}},"URL":"https:\/\/doi.org\/10.1373\/clinchem.2006.073460","relation":{},"ISSN":["0009-9147","1530-8561"],"issn-type":[{"value":"0009-9147","type":"print"},{"value":"1530-8561","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2006,9,1]]},"published":{"date-parts":[[2006,9,1]]}}}